AltheRx Pharmaceuticals Inks $15M
Clinical development company AltheRx Pharmaceuticals has announced a restructuring – which includes $15 million in fresh capital – and has also named Jim Bennethum as chief executive officer. Bennethum joins from Becker Ventures, where he is executive vice president. The company also said that Jeffrey O’Donnell, managing director of BioStar Ventures, will serve as Vice Chair of its Board.
2 May 2013•4 mins read
